Scientists have uncovered a molecular signaling pathway involving Stat3 and Fam3a proteins that regulates how muscle stem cells decide whether to self-renew or differentiate - an insight that could lead to muscle-boosting therapeutics for muscular dystrophies or age-related muscle decline
Sasikumar Kilaikode from LSU Health Shreveport presented a talk on Obstructive Sleep Apnea in children, with respect to identifying its signs and early intervention in order to prevent complications.
Sumeet Singh Miiter from Icahn School of Medicine presented a talk on Cardiac Amyloidosis with respect to recognising burden and different causes of heart failure with preserved ejection fracture, discussing novel diagnostics and therapeutics for cardiac amyloidosis.
Zachary Bloomgarden from Icahn School of Medicine presented a talk on HbA1c in Diabetes Management with respect to quantitating glycemic exposure, Glycemic variability and managing outcomes related to glycemia.
Dr. Patrick Kamath from UW Department of Medicine presented a talk on changes that take place in the liver in patients with a Cardiac Disease with the help of different cases and related statistics.
In this case review, vRad Chief Medical Officer, Dr. Benjamin W. Strong, utilizes cinematic and still imagery to explore the findings and diagnosis of some of his favorite cases complied from vRad’s extensive teaching library.
Dr, Socinski discusses new applications for immunotherapy in the treatment of patients with non–small cell lung cancer. There are 2 basic elements that providers have to get right - one is the diagnosis, which includes histology and PD-L1 status, or molecular status in stage IV disease. The second important factor is the disease stage. Socinski said that researchers are enthusiastic about the progress with these therapies in stage IV disease and are hopeful these advances can extend into earlier settings.
Dr. Olszanski discusses the treatment selection process for use of cemiplimab (Libtayo) in patients with cutaneous squamous cell carcinoma (CSCC). For patients with CSCC who are referred to the medical oncologist, this means the surgeon has indicated that they are not candidates for surgical resection. In this case, a multidisciplinary team including the surgeon, radiation oncologist, medical oncologist, and a dermatologist will need to review the case to determine the best treatment plan, says Olszanski.
Rheumatoid Arthritis impacts many individuals. Dr. Anthony Kopiecki explains how a new treatment can help those with RA relieve pain in a personalized way.
This video is enlarged turbiate reduction using the fradiofrequency and out-fracture technique. This technique can preserve the mucosa of turbinate and thus can avoid the side effect of turbinate surgey, such as empty nose syndome.